Provided by Tiger Trade Technology Pte. Ltd.

MAIA Biotechnology Inc.

1.54
+0.01000.65%
Post-market: 1.540.00000.00%16:10 EDT
Volume:660.71K
Turnover:999.22K
Market Cap:90.34M
PE:-2.00
High:1.54
Open:1.52
Low:1.48
Close:1.53
52wk High:3.19
52wk Low:0.8700
Shares:58.66M
Float Shares:28.34M
Volume Ratio:0.75
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7683
EPS(LYR):-1.0476
ROE:-2691.07%
ROA:-148.38%
PB:2167.89
PE(LYR):-1.47

Loading ...

MAIA Biotechnology Expands Phase 2 Study in Romania

TIPRANKS
·
Nov 20, 2025

MAIA Biotechnology CEO presents at Smart Diaspora 2025

TIPRANKS
·
Nov 20, 2025

MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania’s 2025 Smart Diaspora Conference on Oncology Research and Innovation

GlobeNewswire
·
Nov 20, 2025

MAIA Biotechnology’s Innovative Approach in NSCLC Treatment: A Phase 2 Study Update

TIPRANKS
·
Oct 28, 2025

MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire
·
Oct 27, 2025

MAIA Biotechnology Showcases Promising Cancer Trial Results

TIPRANKS
·
Oct 23, 2025

MAIA Biotechnology details 30-month patient survival in Phase 2 trial of NSCLC

TIPRANKS
·
Oct 23, 2025

Maia Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Oct 23, 2025

BRIEF-Maia Biotechnology Announces $736,600 Private Placement

Reuters
·
Oct 14, 2025

MAIA Biotechnology to sell 603,769 shares at $1.22 in private placement

TIPRANKS
·
Oct 14, 2025

MAIA Biotechnology Announces $736,600 Private Placement

GlobeNewswire
·
Oct 14, 2025

MAIA Biotechnology Adopts New Digital Asset Strategy

TIPRANKS
·
Oct 07, 2025

MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets

GlobeNewswire
·
Oct 07, 2025

Maia Biotechnology Director Stan Smith Reports Acquisition of Common Shares

Reuters
·
Oct 03, 2025

MAIA Biotechnology announces $2.25M private placement

TIPRANKS
·
Sep 30, 2025

MAIA Biotechnology Announces $2.25 Million Private Placement

GlobeNewswire
·
Sep 30, 2025

MAIA Biotechnology Secures NIH Grant for THIO-101 Trial

TIPRANKS
·
Sep 25, 2025

MAIA Biotechnology awarded $2.3M grant by NIH for THIO-101

TIPRANKS
·
Sep 24, 2025

MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent

GlobeNewswire
·
Sep 24, 2025

MAIA Biotechnology Inducement Offer with Investors

TIPRANKS
·
Sep 19, 2025